Cerebral Organoid Model Reveals How Ebola Virus Persists in the Brain for Months
Key Insights
Researchers used human cerebral organoids to demonstrate that Ebola virus (search) can productively persist in brain tissue for up to 120 days, infecting neurons, astrocytes, and microglia.
The study found that Ebola virus (search) spreads via both cell-to-cell transmission and traditional budding, while late-stage infection triggers pro-inflammatory cytokine responses that fail to clear the virus.
Defective viral genomes and specific mutations identified in persistently infected organoids may explain how the virus evades immune detection and maintains long-term infection.
An international research collaboration has harnessed human cerebral organoids to uncover the mechanisms by which Ebola virus (search) (EBOV) establishes long-term persistence in the brain, offering critical insights into why survivors can experience relapses and inflammatory complications months after recovering from the acute phase of the disease.
The study, published in Nature Microbiology, was led by researchers at the Bernhard Nocht Institute for Tropical Medicine (search) (BNITM) in Hamburg, Germany, and the Icahn School of Medicine at Mount Sinai in New York. Using cerebral organoids derived from human induced pluripotent stem cells, the team investigated how filoviruses—including EBOV, Sudan virus (search) (SUDV), and Marburg virus (search) (MARV)—infect and persist within central nervous system tissue.
Productive persistence across multiple brain cell types
The researchers observed productive persistent infection with EBOV, SUDV, and MARV in cerebral organoids for up to 120 days. Ebola virus (search) was found to infect a broad range of cerebral cell types, including neurons, astrocytes, oligodendrocytes, and microglia—the brain's resident immune cells. Critically, the virus did not remain in a dormant or inactive state; rather, it continued to replicate and spread, representing what the authors describe as "productive persistence."
“These cerebral organoids enable us to investigate in detail the mechanisms that Ebola virus (search) and other filoviruses use to persist in the human central nervous system,” said Lina Widerspick, PhD, first author of the publication and former researcher at BNITM. “Through experiments in this model system, we can gain insights that help us improve our understanding of the long-term effects of persistence, like the severe and sometimes fatal inflammation seen in Ebola virus disease survivors with meningoencephalitis.”
Dual modes of viral spread
Further investigation into the mechanisms facilitating persistence revealed that EBOV employs two distinct modes of transmission within cerebral organoids: direct cell-to-cell transmission and classical budding from the host cell. This dual strategy may help the virus evade extracellular immune defenses while simultaneously enabling broader dissemination through the tissue.
Immune response fails to control infection
In the later stages of infection, the cerebral organoids produced pro-inflammatory cytokines, signaling an elevated immune response. However, this response proved insufficient to curb the infection. “We therefore conclude that a persistent Ebola virus (search) infection in immune-privileged tissues can lead to local inflammation. This observation is consistent with the fact that some Ebola virus disease survivors develop inflammation of the eye, meninges, or brain months after infection with Ebola virus,” explained César Muñoz-Fontela, PhD, head of the Virus Immunology research group at BNITM and co-senior author of the study.
Viral genome mutations linked to persistence
The research team also identified defective viral genomes and particles, along with mutations in EBOV genomes, in late-stage persistently infected cerebral organoids. These genetic alterations may contribute to viral persistence by limiting intracellular detection and suppressing replication to a level that avoids triggering robust immune clearance.
“Many of these mutations had been proposed to reduce or prevent viral replication in naturally occurring infections. Because Ebola virus (search) behaves similarly in this model system to how it does in human infections, this underscores the suitability of our cerebral organoids for investigating filovirus persistence,” said Gustavo Palacios, PhD, Professor of Microbiology at the Icahn School of Medicine and co-last author of the publication.
The researchers also identified mutations not previously described in Ebola virus (search) disease survivors, and further studies are needed to determine whether these mutations are causally linked to filovirus persistence.
Implications for drug development and future research
Beyond elucidating mechanisms of viral persistence, the study highlights the broader potential of cerebral organoids as a platform for investigating host–virus interactions in immune-privileged tissues. The model may help optimize antiviral development and reduce reliance on animal models in infectious disease research. The authors emphasize that additional long-term studies and a more diverse investigation of filoviruses—including Reston, Taï Forest, Bombali, and Bundibugyo viruses—are needed to provide a more complete characterization of filoviral persistence mechanisms.